Bleomycin medac, 15 000 RÜ süstelahuse pulber
ORI2025-46
Phase 2 small_molecule active
Quick answer
Bleomycin medac, 15 000 RÜ süstelahuse pulber for VASCULAR MALFORMATION is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- VASCULAR MALFORMATION
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active